drugset

drugset / Trial / NCT00314860

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

NCT00314860 ↗

Phase 3 Completed 568 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

Restless Legs Syndrome (RLS) study in adults comparing immediate release ropinirole with extended release ropinirole over 12 weeks

Timeline

Start: 2006-02
Primary completion: 2006-12
Completion: 2006-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ropinirole	Small molecule	—	—

Indications